Yang Huang
Stock Analyst at J.P. Morgan
(4.81)
# 476
Out of 4,634 analysts
120
Total ratings
71.4%
Success rate
36%
Average return
Main Sectors:
Stocks Rated by Yang Huang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $113.00 → $117.00 | $97.30 | +20.25% | 19 | Aug 6, 2026 | |
| HKG: 9995 RemeGen Co., Ltd. | Maintained: Buy | $129.00 | $84.75 | +52.21% | 14 | Aug 6, 2026 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Maintained: Buy | $138.00 → $150.00 | $198.00 | -24.24% | 11 | Mar 26, 2026 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $499.00 → $545.00 | $528.50 | +3.12% | 2 | Nov 24, 2025 | |
| HKG: 1877 Shanghai Junshi Biosciences Co., Ltd. | Maintained: Sell | $18.00 → $20.00 | $19.42 | +2.99% | 9 | Oct 30, 2025 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Maintained: Sell | $37.00 → $38.00 | $40.56 | -6.31% | 8 | Oct 29, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Initiated Coverage: Buy | $43.00 | $34.54 | +24.49% | 1 | Sep 25, 2025 | |
| HKG: 1276 Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Initiated Coverage: Hold | $78.00 | $57.95 | +34.60% | 1 | Sep 23, 2025 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $99.00 → $166.00 | $101.50 | +63.55% | 11 | Aug 27, 2025 | |
| HKG: 1548 Genscript Biotech Corporation | Maintained: Buy | $16.00 → $24.00 | $24.16 | -0.66% | 2 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36.00 → $37.00 | $46.12 | -19.77% | 10 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46.00 → $74.00 | $62.55 | +18.31% | 6 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52.00 → $93.00 | $36.34 | n/a | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84.00 → $80.00 | $40.08 | n/a | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $186.00 → $183.60 | $213.20 | n/a | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3.40 | $2.45 | n/a | 1 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $217 → $64 | $23.57 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4.80 → $3.00 | $2.12 | n/a | 3 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26.50 | $7.87 | n/a | 1 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14.00 | $8.63 | n/a | 4 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18.00 | $12.16 | n/a | 2 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $9.00 → $11.00 | $18.00 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 → $169 | $359.00 | n/a | 4 | Mar 26, 2020 |
Innovent Biologics, Inc.
Aug 6, 2026
Maintained: Buy
Price Target: $113.00 → $117.00
Current: $97.30
Upside: +20.25%
RemeGen Co., Ltd.
Aug 6, 2026
Maintained: Buy
Price Target: $129.00
Current: $84.75
Upside: +52.21%
WuXi AppTec Co., Ltd.
Mar 26, 2026
Maintained: Buy
Price Target: $138.00 → $150.00
Current: $198.00
Upside: -24.24%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Nov 24, 2025
Maintained: Buy
Price Target: $499.00 → $545.00
Current: $528.50
Upside: +3.12%
Shanghai Junshi Biosciences Co., Ltd.
Oct 30, 2025
Maintained: Sell
Price Target: $18.00 → $20.00
Current: $19.42
Upside: +2.99%
Hangzhou Tigermed Consulting Co., Ltd
Oct 29, 2025
Maintained: Sell
Price Target: $37.00 → $38.00
Current: $40.56
Upside: -6.31%
Hansoh Pharmaceutical Group Company Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $43.00
Current: $34.54
Upside: +24.49%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Sep 23, 2025
Initiated Coverage: Hold
Price Target: $78.00
Current: $57.95
Upside: +34.60%
Akeso, Inc.
Aug 27, 2025
Maintained: Buy
Price Target: $99.00 → $166.00
Current: $101.50
Upside: +63.55%
Genscript Biotech Corporation
Aug 21, 2025
Maintained: Buy
Price Target: $16.00 → $24.00
Current: $24.16
Upside: -0.66%
Aug 21, 2025
Maintained: Buy
Price Target: $36.00 → $37.00
Current: $46.12
Upside: -19.77%
Aug 14, 2025
Maintained: Buy
Price Target: $46.00 → $74.00
Current: $62.55
Upside: +18.31%
Aug 7, 2025
Maintained: Buy
Price Target: $52.00 → $93.00
Current: $36.34
Upside: n/a
May 16, 2023
Maintained: Buy
Price Target: $84.00 → $80.00
Current: $40.08
Upside: n/a
Mar 7, 2023
Maintained: Buy
Price Target: $186.00 → $183.60
Current: $213.20
Upside: n/a
Feb 22, 2023
Upgraded: Buy
Price Target: $3.40
Current: $2.45
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $217 → $64
Current: $23.57
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $4.80 → $3.00
Current: $2.12
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $26.50
Current: $7.87
Upside: n/a
Aug 31, 2021
Maintained: Buy
Price Target: $14.00
Current: $8.63
Upside: n/a
Aug 27, 2021
Maintained: Hold
Price Target: $18.00
Current: $12.16
Upside: n/a
Jun 29, 2021
Downgraded: Hold
Price Target: $9.00 → $11.00
Current: $18.00
Upside: n/a
Mar 26, 2020
Maintained: Buy
Price Target: $230 → $169
Current: $359.00
Upside: n/a